The Internationalization emerges as a joint action of the Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Rare Diseases (CIBERER) and Respiratory Diseases (CIBERES) research areas of the Biomedical Research Networking Center (CIBER). The Platform final goal is to coordinate and reinforce the efforts devoted to promote the participation of ours researchers in the European Framework programs and to create a common structure to drive the internationalization and leadership of the research and innovation within the three thematic areas.
The main objectives of the platform are:
The Biomedical Research Networking Center in their thematic areas of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Rare Diseases (CIBERER) and Respiratory Diseases (CIBERES) constitute 3 research consortiums created under the leadership of the Carlos III Health Institute (ISCIII). The networking structure of CIBER allows to bring together the best basic science, clinical and epidemiological researches from Universities, Healthcare and Research centers. Within their Biomaterials, Respiratory and Rare Diseases areas the CIBER groups more than 140 research groups and more than a thousand of professionals.
Our technology offer includes a wide plethora of areas including:
If you are interested in learning more about our technology offer or are interested in collaborate with us please contact:
The Internationalization supports researchers during the application phase to European programs making available a helpdesk service. The helpdesk service is created to support researchers in finding partners, strategic alignment of the proposal and a budget review. If you need help during project application please contact us:
For formal aspects of management:
|Bioengineering, Biomaterials and Nanomedicine
Attached to Scientific Director
Phone: + 34 876 555 474 / +34 636 304 503
|CIBERER Scientific management dep.
Phone: + 34 671 481 672
|Javier Muñoz Bravo
Phone: +34 673 799 994
For strategic items and proposal positioning: